HOAt → HCID 131730209、化合物

HRID 387667ノート

反応式

HRID 387667 の反応式
Cl.[NH2:2][C@@H](CC1C=C(F)C=C(F)C=1)[C@H](O)CNC1(C2C=CC=C(C(F)(F)F)C=2)CC1.[CH3:30][S:31]([NH:34][C:35]1[CH:36]=[C:37]([C:53]([OH:55])=O)[C:38]2[CH2:39][CH2:40][N:41]([CH:46]([CH2:50][CH2:51][CH3:52])[CH2:47][CH2:48][CH3:49])[C:42](=[O:45])[C:43]=2[CH:44]=1)(=[O:33])=[O:32].ON1C2N=CC=CC=2N=N1.Cl.CN(C)CCCN=C=NCC>CN(C)C=O.C(OCC)(=O)C.O.C(N(CC)CC)C>[CH3:30][S:31]([NH:34][C:35]1[CH:36]=[C:37]([C:53]([NH2:2])=[O:55])[C:38]2[CH2:39][CH2:40][N:41]([CH:46]([CH2:50][CH2:51][CH3:52])[CH2:47][CH2:48][CH3:49])[C:42](=[O:45])[C:43]=2[CH:44]=1)(=[O:32])=[O:33]

参加物

9

反応物 4

HCID 181649HOAtHCID 27239391,3-Propanediamine, N'-(ethylcarbonimidoyl)-N,N-dimethyl-, monohydrochlorideHCID 68471216HCID 68471216、化合物HCID 86643873HCID 86643873、化合物

生成物 1

HCID 131730209HCID 131730209、化合物

試薬・触媒・溶媒 4

HCID 962Water溶媒HCID 6228Dimethylformamide溶媒HCID 8471Triethylamine溶媒HCID 8857Ethyl Acetate溶媒

実験手順

Added to a solution of 185 mg of (2R,3S)-3-amino-4-(3,5-difluorophenyl)-1-({1-[3-(trifluoromethyl)phenyl]cyclopropyl}amino)butan-2-ol hydrochloride (2:1), 150 mg of 7-[(methylsulfonyl)amino]-1-oxo-2-(1-propylbutyl)-1,2,3,4-tetrahydroisoquinoline-5-carboxylic acid and 0.176 cm3 of triethylamine in 1.6 cm3 of anhydrous dimethylformamide are 64 mg of 1-hydroxy-7-azabenzotriazole then 90 mg of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride. The solution is kept stirring for 24 h at a temperature close to 20° C. 20 cm3 of water and 50 cm3 of ethyl acetate are added to the reaction medium. After decantation, the organic phase is washed with 20 cm3 of a saturated aqueous solution of ammonium chloride, five lots of 20 cm3 of water, 20 cm3 of saturated aqueous solution of sodium chloride, then dried over anhydrous magnesium sulfate, filtered and concentrated to dryness under reduced pressure (5 kPa). The residual solution (around 3 cm3) is filtered through a pellet of 15 g of 40-63 μm silica. The silica pellet is washed with 75 cm3 of ethyl acetate. The filtrate is concentrated to dryness under reduced pressure (5 kPa). 300 mg of N-[(1S,2R)-1-(3,5-difluorobenzyl)-2-hydroxy-3-({1-[3-trifluoromethyl)phenyl]cyclopropyl}amino)propyl]-7-[(methylsulfonyl)amino]-1-oxo-2-(1-propylbutyl)-1,2,3,4-tetrahydroisoquinoline-5-carboxamide are obtained in the form of a directly salified white powder.

後処理

  1. customclose to 20° C
  2. washAfter decantation, the organic phase is washed with 20 cm3 of a saturated aqueous solution of ammonium chloride, five lots of 20 cm3 of water, 20 cm3 of saturated aqueous solution of sodium chloride
  3. dry with materialdried over anhydrous magnesium sulfate
  4. filtrationfiltered
  5. concentrationconcentrated to dryness under reduced pressure (5 kPa)
  6. filtrationThe residual solution (around 3 cm3) is filtered through a pellet of 15 g of 40-63 μm silica
  7. washThe silica pellet is washed with 75 cm3 of ethyl acetate
  8. concentrationThe filtrate is concentrated to dryness under reduced pressure (5 kPa)

出典と根拠

ORDレコード
ord-479f1b1a81b8466fa2d63f28071f0f6b
出典データセット
uspto-grants-2013_02
特許番号
US08372864B2

反応ノート

読み込み中…